JHEP Reports

Scope & Guideline

Fostering collaboration for groundbreaking health solutions.

Introduction

Welcome to the JHEP Reports information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JHEP Reports, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherELSEVIER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationJHEP REP / JHEP Rep.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

JHEP Reports is focused on advancing the understanding and treatment of liver diseases. The journal emphasizes the integration of clinical findings with molecular and cellular mechanisms, aiming to bridge the gap between basic research and clinical application. It serves as a platform for innovative research in hepatology, particularly in areas related to liver cancer, hepatitis, liver transplantation, and metabolic liver diseases.
  1. Liver Disease Pathophysiology:
    Investigation into the underlying mechanisms and biological pathways involved in various liver diseases, including viral hepatitis, metabolic dysfunction-associated liver disease, and hepatocellular carcinoma.
  2. Clinical Management and Therapeutics:
    Studies addressing the clinical management of liver diseases, including novel therapeutic approaches, patient management strategies, and the impact of treatments on patient outcomes.
  3. Translational Research:
    Research that translates findings from basic science into clinical practice, focusing on biomarkers, therapeutic targets, and the efficacy of interventions in liver disease.
  4. Epidemiology and Public Health:
    Exploration of the epidemiological trends, risk factors, and public health implications associated with liver diseases, emphasizing the need for effective screening and prevention strategies.
  5. Innovative Diagnostic Techniques:
    Development and validation of new diagnostic tools and biomarkers for the early detection and monitoring of liver diseases, enhancing the precision of clinical assessments.
The landscape of liver disease research is evolving, with several themes emerging as particularly relevant in recent years. These trends reflect the ongoing advancements in understanding liver pathology and the development of innovative treatment strategies.
  1. Immunotherapy for Liver Cancer:
    There is a growing interest in exploring immunotherapeutic approaches for hepatocellular carcinoma, reflecting a broader trend in oncology towards harnessing the immune system to target cancer.
  2. Metabolic Liver Diseases:
    Research on metabolic dysfunction-associated fatty liver disease (MAFLD) is increasingly prominent, reflecting the rising global burden of obesity-related liver conditions and their complexities.
  3. Precision Medicine and Personalized Approaches:
    Emerging studies are increasingly focusing on personalized treatment plans based on genetic, metabolic, and immunological profiles, tailored to improve outcomes in liver disease patients.
  4. Microbiome and Liver Health:
    The exploration of the gut-liver axis and the role of the microbiome in liver disease pathogenesis and treatment is gaining traction, highlighting the interconnectedness of systems in health.
  5. Non-Invasive Biomarkers:
    There is a significant trend towards the development and validation of non-invasive biomarkers for liver disease diagnosis and monitoring, as researchers seek to reduce reliance on invasive procedures.

Declining or Waning

While JHEP Reports continues to publish a wide array of studies, certain themes appear to be losing prominence over recent years. This shift may reflect changing research priorities or advancements in treatment modalities that reduce the relevance of older topics.
  1. Traditional Imaging Techniques:
    There is a noticeable decline in studies focused solely on traditional imaging methods for liver disease diagnosis, as newer, more sophisticated techniques and biomarkers gain traction.
  2. Hepatitis C Management:
    Research specifically centered on hepatitis C management has waned, likely due to the successful implementation of direct-acting antiviral therapies that have transformed treatment approaches.
  3. Liver Disease Epidemiology in Stable Populations:
    There seems to be a decrease in studies that focus on static epidemiological data from stable populations, with a shift towards dynamic, real-time analyses that capture emerging trends and variations.
  4. Basic Science of Non-Alcoholic Fatty Liver Disease (NAFLD):
    Research detailing basic mechanisms of NAFLD appears to be declining as the focus shifts towards more clinically relevant studies that explore treatment outcomes and patient management.
  5. Palliative Care Approaches in Hepatology:
    The emphasis on palliative care strategies in liver disease management is decreasing, possibly as more effective curative and management options become available.

Similar Journals

SEMINARS IN LIVER DISEASE

Pioneering discussions in the field of hepatology.
Publisher: THIEME MEDICAL PUBL INCISSN: 0272-8087Frequency: 4 issues/year

SEMINARS IN LIVER DISEASE is a premier journal dedicated to advancing the field of hepatology, published by THIEME MEDICAL PUBL INC. Established in 1981, it has become a respected resource within the academic community, providing high-quality peer-reviewed articles that cover a broad range of topics related to liver diseases. With an impressive impact factor and recognized as a Q1 journal in the hepatology category, it ranks 17th out of 82 journals in the field, placing it in the top 21% of its category according to Scopus rankings. Although it does not offer open access, the journal’s rigorous standards and extensive network ensure that it reaches a wide audience of clinicians, researchers, and students, fostering knowledge and innovation in liver disease management. The journal's objectives focus on disseminating critical insights and promoting informed discussions that can pave the way for future research and clinical advancements in hepatology.

Canadian Journal of Gastroenterology and Hepatology

Exploring Innovations in Liver and Gastrointestinal Health
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

International Journal of Hepatology

Unveiling critical research to transform liver care.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

Frontline Gastroenterology

Advancing the Frontiers of Gastroenterology
Publisher: BMJ PUBLISHING GROUPISSN: 2041-4137Frequency: 4 issues/year

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.

Korean Journal of Gastroenterology

Fostering Global Dialogue on Digestive Health
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

JGH Open

Bridging Knowledge Gaps in Digestive Health
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

HEPATOLOGY

Pioneering innovative solutions for liver health challenges.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0270-9139Frequency: 12 issues/year

HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.

World Journal of Hepatology

Leading the way in hepatology research and education.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1948-5182Frequency: 12 issues/year

World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.

JOURNAL OF HEPATOLOGY

Unraveling the Complexities of Liver Diseases
Publisher: ELSEVIERISSN: 0168-8278Frequency: 12 issues/year

JOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.

Journal of Gastrointestinal and Liver Diseases

Exploring Innovations in Digestive Medicine
Publisher: MEDICAL UNIV PRESSISSN: 1841-8724Frequency: 4 issues/year

The Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.

With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.